KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Change in Acquisitions & Divestments (2016 - 2025)

Edwards Lifesciences (EW) has 16 years of Change in Acquisitions & Divestments data on record, last reported at -$2.0 billion in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 325.1% year-over-year to -$2.0 billion; the TTM value through Dec 2025 reached $62.1 million, up 8.0%, while the annual FY2025 figure was $62.1 million, 8.0% up from the prior year.
  • Change in Acquisitions & Divestments reached -$2.0 billion in Q4 2025 per EW's latest filing, down from $2.1 billion in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $2.1 billion in Q3 2025 and bottomed at -$2.0 billion in Q4 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $38.8 million, with a median of $33.8 million recorded in 2021.
  • Peak YoY movement for Change in Acquisitions & Divestments: plummeted 509.47% in 2023, then surged 430.0% in 2024.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $128.0 million in 2021, then decreased by 25.78% to $95.0 million in 2022, then tumbled by 509.47% to -$389.0 million in 2023, then decreased by 23.8% to -$481.6 million in 2024, then tumbled by 325.1% to -$2.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were -$2.0 billion in Q4 2025, $2.1 billion in Q3 2025, and $14.3 million in Q2 2025.